LGALS3 and pulmonary arterial hypertension: Another study further supported Galectin-3 as a potential biomarker, showing elevated levels of Galectin-3 and aldosterone in patients with IPAH and CTD-PAH, suggesting their relevance in assessing disease severity and progression [75].